Low muscle mass, obesity, and cause‑specific mortality in cancer patients: a nationwide cohort study September 5, 2026 Read More »
MD Anderson and Phoenix SENOLYTIX announce cross-licensing agreement of CaspaCIDe™ for cell and gene therapies September 5, 2025 Read More »